ARGENTINA APPROVES APPLIED BIOSYSTEMS' VIROSEQ KIT.
The Ministry of Health granted its approval after subjecting the ViroSeq system to rigorous validation tests, conducted by Drs. Jorge Benetucci and Juan Carlos Garberi at the Foundation for the Study of Immunodeficiency. The Foundation is an affiliate of Hospital General de Infecciosos F. J. Muniz , a reference hospital in Argentina dedicated to infectious diseases. Clinicians there will use the ViroSeq system to conduct in vitro studies of the HIV-1 virus.
According to Stan Weinstein, senior marketing manager for molecular diagnostics, "This action by the Ministry of Health in Buenos Aires opens up an important market for us. We have always believed that the ViroSeq system is a valuable tool in the war against HIV-1, and we are extremely pleased that the Argentine government has approved our application."
A pioneer and market leader in the development and manufacture of automated systems for life science research, Applied Biosystems is also becoming a market leader in the emerging field of molecular diagnostics. It hopes eventually to establish its HIV-1 genotyping system as an important diagnostic tool in clinical laboratories around the world.
The ViroSeq system is currently marketed in the US as a Research-Use-Only ( RUO) product. Applied Biosystems is diligently working for FDA authorization to market the ViroSeq system in the US for In Vitro Diagnostics (IVD) use
About PE Corporation
PE Corporation comprises two operating groups. The PE Biosystems Group, now conducting business under the Applied Biosystems name, develops and market s instrument-based systems, reagents, software and contract services to the life science industry and research community. Applied Biosystems is headquartered in Foster City, Calif. and reported sales of $1.4 billion during fiscal 2000. The Celera Genomics Group (NYSE: CRA), headquartered in Rockville, Md., intends to become the definitive source of genomic and related medical information. Visit http://www.pecorporation.com or call 800.762.6923.
For more information, call 800.345.5224 or 650.638.6443 or visit http://www.appliedbiosystems.com.
|Printer friendly Cite/link Email Feedback|
|Date:||Jan 1, 2001|
|Previous Article:||HIGHER DOSES OF INTERFERON BETA-1A GIVE NO ADDED BENEFIT.|
|Next Article:||AUSTRALIA APPROVES CARDIAC SCIENCES' POWERHEART.|
|APPLIED BIOSYSTEMS/BRAZILIAN NMH SIGN PACT FOR GENOTYPING.|
|Applied Science: Brazil has its AIDS epidemic nearly cornered. Genetic sleuthing could help seal the deal. (Genetics).|